Live Breaking News & Updates on Astrazeneca 039 s

Stay informed with the latest breaking news from Astrazeneca 039 s on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Astrazeneca 039 s and stay connected to the pulse of your community

AstraZeneca's Enhertu indication gets US approval, Caledonia Investments posts solid growth

London open
The FTSE 100 is expected to open nine points higher on Monday, having closed down 0.81% on Friday at 7,911.16.

Denver , Colorado , United-states , China , Paris , France-general- , France , Singapore , Caledonia , Texas , Phoenix , Arizona

AstraZeneca's Enhurtu cancer gets US green light for adult patients

AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Texas , United-states , University-of-texas-md-anderson-cancer-center , Funda-meric-bernstam , Astrazeneca-039-s , Enhurtu , Cancer , Gets , Green , Light , Adult

AstraZeneca's blood-disorder drug recommended for EU approval

European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Marc-dunoyer , Astrazeneca , Medicinal-products , Human-use , European-medicines-agency , Astrazeneca-039-s , Blood-disorder , Drug , Recommended , Approval , Category-all , Category-company-news

AstraZeneca's Tagrisso gains FDA approval

Drugmaker AstraZeneca traded higher early on Monday after revealing that a combination of its cancer drug Tagrisso with chemotherapy had gained US approval to treat a particular type of lung cancer.

Drug-administration , Astrazeneca , Astrazeneca-039-s , Tagrisso , Gains , Approval , Category-all , Category-market-report , Category-company-news , Category-news-and-announcements , Category-market-pulse

AstraZeneca's Imfinzi shows positive results for endometrial cancer patients

AstraZeneca said results from a Phase III trial showed its Imfinzi treatment in combination with chemotherapy showed a significant improvement in patients with endometrial cancer.

Astrazeneca-039-s , Imfinzi , Shows , Positive , Results , Endometrial , Cancer , Patients , Category-all , Category-company-news , Category-news-and-announcements

AstraZeneca's Farxiga heart failure drug gets extended US approval

AstraZeneca's Farxiga drug has been approved in the US to reduce the risk of cardiovascular death, hospitalisation for heart failure and urgent heart failure visits in adults, the company said on Tuesday.

Drug-administration , Astrazeneca-039-s , Farxiga , Heart , Failure , Drug , Gets , Extended , Approval , Category-all , Category-company-news